Corticosteroid therapy for chronic active hepatitis B: Is a little too much?
- 1 November 1986
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 6 (6), 1416-1418
- https://doi.org/10.1002/hep.1840060633
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Effect of Immunosuppressive Therapy on HBsAg-Positive Chronic Active Hepatitis in Relation to Presence or Absence of HBeAg and Anti-HBeHepatology, 2007
- A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis BHepatology, 1986
- Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitisHepatology, 1986
- Effects of short‐term, high‐dose prednisone treatment of patients with HBsAg‐positive chronic active hepatitisLiver International, 1985
- Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver diseaseJournal of Hepatology, 1985
- Prednisolone in HBsAg-positive chronic active hepatitis: Histologic evaluation in a controlled prospective studyHepatology, 1982
- Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.Gut, 1982
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981
- Deleterious Effect of Prednisolone in HBsAg-positive Chronic Active HepatitisNew England Journal of Medicine, 1981
- SERUM LEVELS OF HEPATITIS B SURFACE AND CORE ANTIGENS DURING IMMUNOSUPPRESSIVE TREATMENT OF HBsAg-POSITIVE CHRONIC ACTIVE HEPATITISThe Lancet, 1980